glp 1 and gerd GLP-1s linked to higher risk in T2D patients: study | Phathom Pharmaceuticals posted on the topic GLP1-GIP receptor co-agonists: a promising

Semaglutide for diabetes (Ozempic) starts at 0.25 mg weekly, whilst semaglutide for weight management (Wegovy) begins at the same dose before titrating to 2.4 mg

Physical Activity: Exercise provides metabolic benefits beyond caloric expenditure

DPP4 deficiency exerts protective effect against H2O2 induced oxidative stress in isolated cardiomyocytes

Choose an Injection Area: Pick your Spot: Decide on injection area: either upper arm, thigh, or abdomen

Karra, E., Chandarana, K

If confirmed in larger prospective trials, these widely used drugs could offer a new potential approach to breast cancer prevention, especially for women with excess body weight